Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reversal of Bowel Obstruction With Platinum-Based Chemotherapy and Olaparib in Recurrent, Short Platinum-Free Interval, RAD51C Germline Mutation-Associated Ovarian Cancer.
Ngoi NYL, Tay D, Heong V, Thian YL, Ong PY, Ow SGW, Jeyasekharan AD, Lim YW, Lim SE, Lee SC, Ng J, Low JJH, Ilancheran A, Koh SZL, Tan DSP. Ngoi NYL, et al. Among authors: lim se, lim yw. JCO Precis Oncol. 2018 Nov;2:1-8. doi: 10.1200/PO.18.00008. JCO Precis Oncol. 2018. PMID: 35135172 No abstract available.
Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer.
Ngoi NYL, Heong V, Lee XW, Huang YQ, Thian YL, Choo BA, Lim D, Lim YW, Lim SE, Ilancheran A, Soong R, Tan DSP. Ngoi NYL, et al. Among authors: lim d, lim se, lim yw. Gynecol Oncol Rep. 2018 Jan 31;24:1-5. doi: 10.1016/j.gore.2018.01.009. eCollection 2018 May. Gynecol Oncol Rep. 2018. PMID: 29892689 Free PMC article.
Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01).
Ngoi NYL, Heong V, Tang JI, Choo BA, Kumarakulasinghe NB, Lim D, Low M, Lim SE, Lim YW, Leong YH, Tseng M, Tong PSY, Ilancheran A, Low JJH, Ng J, Thian YL, Koh V, Tan DSP. Ngoi NYL, et al. Among authors: lim d, lim se, lim yw. Int J Radiat Oncol Biol Phys. 2021 Mar 1;109(3):701-711. doi: 10.1016/j.ijrobp.2020.09.059. Epub 2020 Oct 9. Int J Radiat Oncol Biol Phys. 2021. PMID: 33045316 Clinical Trial.
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
Sachdeva M, Ngoi NYL, Lim D, Poon MLM, Thian YL, Lim YW, Lim SE, Tong P, Lum JHY, Ng J, Ilancheran A, Domingo EJ, Low JJH, Tan DSP. Sachdeva M, et al. Among authors: lim d, lim se, lim yw. Onco Targets Ther. 2021 Jun 29;14:3921-3928. doi: 10.2147/OTT.S309661. eCollection 2021. Onco Targets Ther. 2021. PMID: 34234460 Free PMC article.
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
Lim JSJ, Wong ALA, Ow SGW, Ngoi NYL, Chan GHJ, Ang YLE, Chong WQ, Lim SE, Lim YW, Lee M, Choo JRE, Tan HL, Yong WP, Soo RA, Tan DSP, Chee CE, Sundar R, Yadav K, Jain S, Wang L, Tai BC, Goh BC, Lee SC. Lim JSJ, et al. Among authors: lim se, lim yw. Clin Cancer Res. 2022 Jun 1;28(11):2248-2256. doi: 10.1158/1078-0432.CCR-21-4179. Clin Cancer Res. 2022. PMID: 35363275 Clinical Trial.
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience.
Wijaya ST, Ngoi NY, Loh JW, Tan TZ, Lim D, Khan IS, Thian YL, Lai A, Ang BW, Tong P, Ng J, Low JJ, Ilancheran A, Lim SE, Lim YW, Tan DS. Wijaya ST, et al. Among authors: lim yw. J Gynecol Oncol. 2024 Mar 29. doi: 10.3802/jgo.2024.35.e69. Online ahead of print. J Gynecol Oncol. 2024. PMID: 38606821 Free article.
391 results